/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

Douglas A. Arenberg

University of Michigan–Ann Arbor(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

224

Papers

14.0K

Citations

60

h-index

115

i10-index

Douglas A. Arenberg is an academic researcher from University of Michigan–Ann Arbor. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Chemokine receptors and signaling. The author has an h-index of 60, co-authored 191 publications.

ORCID: 0000-0001-7707-5092

Research Topics

Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations Chemokine receptors and signaling Chronic Obstructive Pulmonary Disease (COPD) Research Cell Adhesion Molecules Research

Papers by this author

works

The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis

1997 · The Journal of Immunology · 384 citations

https://doi.org/10.4049/jimmunol.159.3.1437

Michael P. Keane Douglas A. Arenberg Joseph P. Lynch Richard I. Whyte

Neutralization of the CXC Chemokine, Macrophage Inflammatory Protein-2, Attenuates Bleomycin-Induced Pulmonary Fibrosis

1999 · The Journal of Immunology · 246 citations

https://doi.org/10.4049/jimmunol.162.9.5511

Michael P. Keane John A. Belperio Thomas A. Moore Bethany B. Moore

Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8

1996 · The Journal of Immunology · 230 citations

https://doi.org/10.4049/jimmunol.157.9.4194

Bruno DiGiovine Joseph P. Lynch F.J. Martinez Andrew Flint

IFN-γ-Inducible Protein-10 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via Inhibition of Angiogenesis

1999 · The Journal of Immunology · 212 citations

https://doi.org/10.4049/jimmunol.163.10.5686

Michael P. Keane John A. Belperio Douglas A. Arenberg Marie D. Burdick

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification

2016 · Journal of Thoracic Oncology · 195 citations

https://doi.org/10.1016/j.jtho.2015.12.113

Frank Detterbeck Edith M. Marom Douglas A. Arenberg Wilbur A. Franklin

PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-small Cell Lung Cancer

2005 · Neoplasia · 118 citations

https://doi.org/10.1593/neo.04601

Venkateshwar G. Keshamouni Douglas A. Arenberg Raju C. Reddy Michael J. Newstead

Research topics

topics

Lung Cancer Diagnosis and Treatment

Lung Cancer Treatments and Mutations

Chemokine receptors and signaling

Chronic Obstructive Pulmonary Disease (COPD) Research

Cell Adhesion Molecules Research

Chat about Author

Papers

Chat

Click to start Chat